Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Stewardson, Andrew J
Huttner, Benedikt
and
Harbarth, Stephan
2011.
At least it won’t hurt: the personal risks of antibiotic exposure.
Current Opinion in Pharmacology,
Vol. 11,
Issue. 5,
p.
446.
Norman, Keri N.
Scott, H. Morgan
Harvey, Roger B.
Norby, Bo
Hume, Michael E.
and
Andrews, Kathleen
2011.
Prevalence and Genotypic Characteristics of Clostridium difficile in a Closed and Integrated Human and Swine Population.
Applied and Environmental Microbiology,
Vol. 77,
Issue. 16,
p.
5755.
Aldeyab, Mamoon A.
McElnay, James C.
Scott, Michael G.
Davies, Elizabeth
Edwards, Collette
Elhajji, Feras W. Darwish
Conlon, Geraldine
Magee, Fidelma A.
Barr, Paul J.
and
Kearney, Mary P.
2011.
An Evaluation of the Impact of a Single-Dose Intravenous Immunoglobulin Regimen in the Treatment of Clostridium difficile Infections.
Infection Control & Hospital Epidemiology,
Vol. 32,
Issue. 6,
p.
631.
Moehring, Rebekah W.
and
Anderson, Deverick J.
2012.
Antimicrobial Stewardship as Part of the Infection Prevention Effort.
Current Infectious Disease Reports,
Vol. 14,
Issue. 6,
p.
592.
Aldeyab, M. A.
Kearney, M. P.
Scott, M. G.
Aldiab, M. A.
Alahmadi, Y. M.
Darwish Elhajji, F. W.
Magee, F. A.
and
McElnay, J. C.
2012.
An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
Journal of Antimicrobial Chemotherapy,
Vol. 67,
Issue. 12,
p.
2988.
Chen, Luke F
and
Anderson, Deverick J
2012.
Efficacy and Safety of Fidaxomicin Compared with Oral Vancomycin for the Treatment of Adults with
Clostridium difficile
-Associated Diarrhea: Data from the OPT-80-003 and OPT-80-004 Studies
.
Future Microbiology,
Vol. 7,
Issue. 6,
p.
677.
Harbarth, Stephan
and
Samore, Matthew H.
2012.
Clostridium: Transmission difficile?.
PLoS Medicine,
Vol. 9,
Issue. 2,
p.
e1001171.
Aldeyab, Mamoon A.
Harbarth, Stephan
Vernaz, Nathalie
Kearney, Mary P.
Scott, Michael G.
Darwish Elhajji, Feras W.
Aldiab, Motasem A.
and
McElnay, James C.
2012.
The impact of antibiotic use on the incidence and resistance pattern of extended‐spectrum beta‐lactamase‐producing bacteria in primary and secondary healthcare settings.
British Journal of Clinical Pharmacology,
Vol. 74,
Issue. 1,
p.
171.
Kim, J.
Kang, J.O.
Kim, H.
Seo, M.-R.
Choi, T.Y.
Pai, H.
Kuijper, E.J.
Sanders, I.
and
Fawley, W.
2013.
Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.
Clinical Microbiology and Infection,
Vol. 19,
Issue. 6,
p.
521.
Jones, A.M.
Kuijper, E.J.
and
Wilcox, M.H.
2013.
Clostridium difficile: A European perspective.
Journal of Infection,
Vol. 66,
Issue. 2,
p.
115.
Jump, Robin LP
2013.
Clostridium Difficile
Infection in Older Adults
.
Aging Health,
Vol. 9,
Issue. 4,
p.
403.
Harbarth, S.
2013.
What can we learn from each other in infection control? Experience in Europe compared with the USA.
Journal of Hospital Infection,
Vol. 83,
Issue. 3,
p.
173.
Bateman, Vhairi M
and
Gould, Ian M
2013.
Microbial Drug Resistance.
p.
160.
Williamson, Deborah A.
Basu, Indira
Freeman, Joshua
Swager, Terri
and
Roberts, Sally A.
2013.
Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: A double-edged sword.
American Journal of Infection Control,
Vol. 41,
Issue. 3,
p.
270.
Oleastro, Mónica
Coelho, Marta
Gião, Marília
Coutinho, Salomé
Mota, Sandra
Santos, Andrea
Rodrigues, João
and
Faria, Domitília
2014.
Outbreak of Clostridium difficilePCR ribotype 027 - the recent experience of a regional hospital.
BMC Infectious Diseases,
Vol. 14,
Issue. 1,
Aldeyab, Mamoon A.
Cliffe, Susan
Scott, Michael
Flanagan, Peter
Kearney, Mary
McElnay, James
and
Aldiab, Motasem
2014.
Risk factors associated with Clostridium difficile infection severity in hospitalized patients.
American Journal of Infection Control,
Vol. 42,
Issue. 6,
p.
689.
Maripuu, Hedvig
Aldeyab, Mamoon A
Kearney, Mary P
McElnay, James C
Conlon, Geraldine
Magee, Fidelma A
and
Scott, Michael G
2014.
An audit of antimicrobial treatment of lower respiratory and urinary tract infections in a hospital setting.
European Journal of Hospital Pharmacy,
Vol. 21,
Issue. 3,
p.
139.
Aldeyab, Mamoon A.
McElnay, James C.
Scott, Michael G.
Lattyak, William J.
Darwish Elhajji, Feras W.
Aldiab, Motasem A.
Magee, Fidelma A.
Conlon, Geraldine
and
Kearney, Mary P.
2014.
A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking.
Journal of Antimicrobial Chemotherapy,
Vol. 69,
Issue. 4,
p.
1132.
Rao, K.
2014.
Measuring the Impact of Clostridium difficile Infection With the NAP1 Strain on Severity and Mortality.
Clinical Infectious Diseases,
Vol. 59,
Issue. 8,
p.
1193.
See, I.
Mu, Y.
Cohen, J.
Beldavs, Z. G.
Winston, L. G.
Dumyati, G.
Holzbauer, S.
Dunn, J.
Farley, M. M.
Lyons, C.
Johnston, H.
Phipps, E.
Perlmutter, R.
Anderson, L.
Gerding, D. N.
and
Lessa, F. C.
2014.
NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection.
Clinical Infectious Diseases,
Vol. 58,
Issue. 10,
p.
1394.